CAS 156436-90-7
:lutetium diacetate (2Z,6Z,11Z,13E,19E,21Z)-4,5-diethyl-9,24-bis(3-hydroxypropyl)-16,17-bis{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-10,23-dimethyl-13,20,25,26,27-pentaazapentacyclo[20.2.1.1~3,6~.1~8,11~.0~14,19~]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21
Description:
Lutetium diacetate, specifically the compound with the complex name provided, is a coordination complex featuring lutetium, a rare earth element, coordinated with acetate ligands. This compound is characterized by its intricate molecular structure, which includes multiple functional groups and a polycyclic framework. The presence of diethyl and hydroxypropyl substituents suggests potential solubility in organic solvents and possible interactions with biological systems. The methoxyethoxy groups may enhance the compound's stability and solubility, making it suitable for various applications in organic synthesis or materials science. Lutetium, being a lanthanide, typically exhibits a +3 oxidation state, and its coordination chemistry is significant in fields such as catalysis and medicinal chemistry. The specific stereochemistry indicated by the (2Z,6Z,11Z,13E,19E,21Z) notation suggests that the compound may exhibit unique optical properties or reactivity patterns. Overall, lutetium diacetate represents a complex and potentially versatile chemical entity with applications in advanced materials and pharmaceuticals.
Formula:C52H74LuN5O15X
InChI:InChI=1/C48H66N5O10.2C2H4O2.Lu.H2O/c1-7-35-36(8-2)40-28-42-38(12-10-14-55)34(4)46(53-42)32-50-44-30-48(63-26-24-61-22-20-59-18-16-57-6)47(62-25-23-60-21-19-58-17-15-56-5)29-43(44)49-31-45-33(3)37(11-9-13-54)41(52-45)27-39(35)51-40;2*1-2(3)4;;/h27-32,54-55H,7-26H2,1-6H3;2*1H3,(H,3,4);;1H2/q-1;;;+3;/p-2/b39-27-,40-28-,41-27-,42-28-,45-31-,46-32-,49-31+,49-43+,50-32+,50-44+;;;;
Synonyms:- Nsc695239
- Motexafin lutetium hydrate
- Lutetium texaphyrin
- (PB-7-11-233'2'4)-Bis(acetato-κO)[9,10-diethyl-20,21-bis[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]-4,15-diMethyl-8,11-iMino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine-5,14-dipropanolato-κN1,κN18,κN23,κN24,κN25]lutetiuM Hydrate
- Bis(acetato-o)[9,10-diethyl-20,21-bis[2-[2-(2-methoxyethoxy) ethoxy]ethoxy]-4,15-dimethyl-8,11-imino-6,3:13,16-dinitrilo -1,18-benzodiazacycloeicosine-5,14-dipropanolato-N1,N18,N23,N24,N25]lutetium hydrate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
Motexafin lutetium hydrate
CAS:<p>Motexafin lutetium hydrate is a radioactive drug that is used in the diagnosis of skin cancer. The drug binds to the chemoattractant protein CXCL1 and pro-apoptotic protein BID, leading to the accumulation of these proteins at the mitochondria membrane potential. This accumulation induces apoptosis by inhibiting mitochondrial activity. Motexafin lutetium hydrate has also been shown to be effective against a number of bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, and Escherichia coli. It has also been shown to have anti-inflammatory effects in animal models, which may be due to its inhibition of prostaglandin synthesis.</p>Formula:C52H74LuN5O15Purity:Min. 95%Molecular weight:1,184.1 g/mol
